disease activity

The Effect of Interleukin 23 Levels on Clinical and Laboratory Parameters of Patients with Ankylosing Spondylitis

Issue:

Vol 69, Issue 4: 2021

DOI:

10.7727/wimj.2015.241

Pages:

222-6

Synopsis:

Ankylosing spondylitis is a progressive disease that should be monitored routinely throughout a patient’s life. IL-23 should be used as a clinical marker, and the findings can be strengthened by the combined information obtained from Ankylosing Spondylitis activity indexes analyses.

ABSTRACT

Objective: In the present study, we aimed to investigate the relationship between interleukin 23 (IL-23) and the clinical and laboratory parameters in patients with ankylosing spondylitis (AS). Ankylosing spondylitis causes structural and functional inability, particularly in the axial skeleton, and results in the inflammatory lower back pain. At the same time, we aimed to investigate the relationship between IL-23 levels and disease related variables in patients with AS.

Received:

18 May, 2015

Accepted:

12 Aug, 2015

Published:

15 Oct, 2021

PDF Attachment: